Universitätsklinikum Tübingen

Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains (2019) Steimle A, Menz S, Bender A, Ball B, Weber ANR, Hagemann T, Lange A, et al. Journal article The course of cancer-related insomnia: don't expect it to disappear after cancer treatment (2019) Schieber K, Niecke A, Geiser F, Erim Y, Bergelt C, Büttner-Teleaga A, Maatouk I, et al. Journal article Laboratory diagnosis of congenital CMV infection in newborns: Impact of pre-analytic factors (2019) Kohmer N, Nagel AM, Berger A, Enders M, Hamprecht K, Korn K, Kortenbusch M, et al. Journal article Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience (2019) Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, et al. Journal article Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD) (2019) Burgmaier K, Kilian S, Bammens B, Benzing T, Billing H, Buescher A, Galiano M, et al. Journal article Efficacy of photodynamic therapy combined with topical interventions for the treatment of actinic keratosis: a meta-analysis (2019) Heppt MV, Steeb T, Leiter U, Berking C Journal article Tolerability of BRAF/MEK inhibitor combinations: Adverse event evaluation and management (2019) Heinzerling L, Eigentler TK, Fluck M, Hassel JC, Heller-Schenck D, Leipe J, Pauschinger M, et al. Journal article, Review article Actual Treatment Options for Giant Cell Arteritis (2019) Moosig F, Schmalzing M, Aries PM, Henes J, Lamprecht P, Rech J, Witte T Journal article Age as a Key Factor in the Pattern, Extent and timing Process of Distant Metastasis in Patients with malignant Melanoma. A Study by the German Central Register of Malignant Melanoma (2019) Gassenmaier M, Leiter U, Eigentler T, Roecken M, Keim U, Gesierich A, Moritz R, et al. Conference contribution A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article